Ademetionine
Ademetionine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
143 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | 1 | 3 | 4 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 1 | 1 | 2 | 4 |
Human influenza | D007251 | EFO_0007328 | J11.1 | — | — | — | 2 | — | 2 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | 1 | 1 | 2 |
Biliary liver cirrhosis | D008105 | K74.3 | — | 1 | — | 1 | — | 2 | |
Knee injuries | D007718 | — | — | — | 1 | — | 1 | ||
Pneumococcal infections | D011008 | EFO_0000772 | J13 | — | — | — | 1 | — | 1 |
Vaccination | D014611 | EFO_0004292 | Z24 | — | — | — | 1 | — | 1 |
Chickenpox | D002644 | EFO_0007204 | B01 | — | — | — | 1 | — | 1 |
Hepatitis b | D006509 | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Depression | D003863 | F33.9 | — | 2 | 1 | — | 4 | 6 | |
Hiv | D006678 | O98.7 | 1 | — | 1 | — | 2 | 4 | |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | 2 | 1 | — | 1 | 3 |
Alcoholic liver diseases | D008108 | EFO_0008573 | K70 | — | — | 1 | — | 1 | 2 |
Tobacco use disorder | D014029 | F17 | — | 1 | 1 | — | 1 | 2 | |
Hepatitis c | D006526 | B19.2 | — | 1 | 1 | — | — | 1 | |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | 1 | — | — | 1 |
Intrahepatic cholestasis | D002780 | — | — | 1 | — | — | 1 | ||
Hepatitis | D006505 | HP_0012115 | K75.9 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 1 | — | — | 1 | 3 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | 1 | — | — | — | 2 |
Hepatocellular carcinoma | D006528 | C22.0 | — | 1 | — | — | — | 1 | |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | 1 | — | — | — | 1 |
Disease | D004194 | EFO_0000408 | R69 | — | 1 | — | — | — | 1 |
Hot flashes | D019584 | — | 1 | — | — | — | 1 | ||
Varicose ulcer | D014647 | — | 1 | — | — | — | 1 | ||
Alcoholic liver cirrhosis | D008104 | EFO_1000802 | K70.3 | — | 1 | — | — | — | 1 |
Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | — | 1 | — | — | — | 1 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | 1 | — | — | — | 1 |
Show 1 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Joint diseases | D007592 | HP_0003040 | M12.9 | — | — | — | — | 5 | 5 |
Neoplasms | D009369 | C80 | — | — | — | — | 4 | 4 | |
Coronary artery disease | D003324 | I25.1 | — | — | — | — | 3 | 3 | |
Postoperative pain | D010149 | G89.18 | — | — | — | — | 3 | 3 | |
Anesthesia | D000758 | — | — | — | — | 2 | 2 | ||
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | — | — | 2 | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | — | 2 | 2 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 2 | 2 |
Colonoscopy | D003113 | — | — | — | — | 2 | 2 | ||
Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 2 | 2 |
Show 69 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | ADEMETIONINE |
INN | ademetionine |
Description | S-Adenosyl methionine (SAM), also known under the commercial names of SAMe, SAM-e, or AdoMet, is a common cosubstrate involved in methyl group transfers, transsulfuration, and aminopropylation. Although these anabolic reactions occur throughout the body, most SAM is produced and consumed in the liver. More than 40 methyl transfers from SAM are known, to various substrates such as nucleic acids, proteins, lipids and secondary metabolites. It is made from adenosine triphosphate (ATP) and methionine by methionine adenosyltransferase. SAM was first discovered by Giulio Cantoni in 1952.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O |
Identifiers
PDB | — |
CAS-ID | 29908-03-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1088977 |
ChEBI ID | 67040 |
PubChem CID | 9865604 |
DrugBank | — |
UNII ID | 7LP2MPO46S (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 193 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
78 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more